JP Morgan Downgrades Cardlytics to Neutral, Announces $58 Price Target

JP Morgan downgrades Cardlytics (NASDAQ:CDLX) from Overweight to Neutral and announces $58 price target.

Benzinga · 11/14/2019 11:06

JP Morgan downgrades Cardlytics (NASDAQ:CDLX) from Overweight to Neutral and announces $58 price target.